Diabetes
Study Findings from Boden Institute of Obesity Broaden Understanding of Diabetes
Published in Drug Week, February 10th, 2012
2012 FEB 10 -- Data detailed in "Optimal management of type 2 diabetes: the evidence" have been presented. "This paper reviews the evidence in relation to the optimal target for HbA1c and outlines a global treatment algorithm for people with type 2 diabetes. While most guidelines recommend a general HbA1c target of 7%, recent large scale intervention studies have examined the potential benefits of lower targets," investigators in Sydney, Australia report.
"These studies have generally shown that lower HbA1c targets provide no macrovascular benefits and limited effects on microvascular complications while increasing rates of hypoglycaemia. Overall these...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2012-02-10)
More Articles from Drug Week
- Blood Coagulation Factors
Studies from Aristotle University Describe New Findings in Blood Coagulation Factors - Clinical Trial Research
Studies from B. Wieseler et al Further Understanding of Clinical Trial Research - Prostate Cancer
Studies from B.X. Hoang and Colleagues Reveal New Findings on Prostate Cancer - Thrombosis
Studies from Biological Research Laboratories Have Provided New Data on Thrombosis - Thrombosis
Studies from Blood Transfusion Institute of Serbia Describe New Findings in Thrombosis - Antitoxins
Studies from Carolinas Medical Center Provide New Data on Antitoxins - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
